| Allyson Tracy Tevrizian, MD | |
|
130 La Casa Via Ste 209 Bldg 2, Walnut Creek, CA 94598-3034 | |
| (925) 935-6252 | |
| (925) 935-7611 |
| Full Name | Allyson Tracy Tevrizian |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 28 Years |
| Location | 130 La Casa Via Ste 209 Bldg 2, Walnut Creek, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902930753 | NPI | - | NPPES |
| A064305 | Other | CA | STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | A064305 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stanford Health Care - Valleycare | Pleasanton, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy And Asthma Medical Group Of The Bay Area Inc | 6507758224 | 19 |
News Archive
More than 59 million Americans age 18 and older were diagnosed with high blood pressure in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects.
Irvine Scientific, a pioneer in developing products specifically for the Assisted Reproductive Technology (ART) community, announced today that the U.S. Food and Drug Administration (FDA) has approved their products intended for vitrification of pronuclear (PN) zygotes through day 3 cleavage and blastocyst stage embryos within the fertility area.
Global demand exists for new ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance.
› Verified 2 days ago
| Entity Name | Allergy & Asthma Medical Group Of The Bay Area Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871550590 PECOS PAC ID: 6507758224 Enrollment ID: O20040326001415 |
News Archive
More than 59 million Americans age 18 and older were diagnosed with high blood pressure in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects.
Irvine Scientific, a pioneer in developing products specifically for the Assisted Reproductive Technology (ART) community, announced today that the U.S. Food and Drug Administration (FDA) has approved their products intended for vitrification of pronuclear (PN) zygotes through day 3 cleavage and blastocyst stage embryos within the fertility area.
Global demand exists for new ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allyson Tracy Tevrizian, MD 370 N Wiget Ln, Ste 210, Walnut Creek, CA 94598-2452 Ph: (925) 935-0856 | Allyson Tracy Tevrizian, MD 130 La Casa Via Ste 209 Bldg 2, Walnut Creek, CA 94598-3034 Ph: (925) 935-6252 |
News Archive
More than 59 million Americans age 18 and older were diagnosed with high blood pressure in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects.
Irvine Scientific, a pioneer in developing products specifically for the Assisted Reproductive Technology (ART) community, announced today that the U.S. Food and Drug Administration (FDA) has approved their products intended for vitrification of pronuclear (PN) zygotes through day 3 cleavage and blastocyst stage embryos within the fertility area.
Global demand exists for new ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance.
› Verified 2 days ago
Dr. Nathan David Schultz, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 130 La Casa Via, Bldg 2, Ste 209, Walnut Creek, CA 94598 Phone: 925-935-6252 Fax: 925-935-7611 | |
Barbara Irene Karpel, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 130 La Casa Via, Bldg 2 Ste 209, Walnut Creek, CA 94598 Phone: 925-930-6252 Fax: 925-930-0942 | |
Dr. Toral Anil Kamdar, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 370 N. Wiget Lane, Suite 210, Walnut Creek, CA 94598 Phone: 925-935-0856 Fax: 925-364-5509 | |
Dr. Nancy Broitman Mozelsio, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 130 La Casa Via, Bldg 2, #209, Walnut Creek, CA 94598 Phone: 925-935-6252 Fax: 925-930-0942 | |
Dr. Joshua Samuel Jacobs, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 130 La Casa Via, Bldg 2, # 209, Walnut Creek, CA 94598 Phone: 925-935-6252 Fax: 925-930-0942 | |
Cynthia Ashbrook, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1450 Treat Blvd, Suite 300, Walnut Creek, CA 94597 Phone: 925-952-2888 | |
Dr. Ilisten Marie Jones, M.D., M.P.H. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 370 N Wiget Ln, Suite 210, Walnut Creek, CA 94598 Phone: 925-935-6252 Fax: 925-930-0942 |